Search
Results: 3
Cross-Neutralisation of Novel Bombali Virus by Ebola Virus Antibodies and Convalescent Plasma Using an Optimised Pseudotype-Based Neutralisation Assay.
Emma M Bentley, Samuel Richardson, Mariliza Derveni, Pramila Rijal, Alain R Townsend, Jonathan L Heeney, Giada Mattiuzzo, Edward Wright
Sep 24, 2021
Ebolaviruses continue to pose a significant outbreak threat, and while Ebola virus (EBOV)-specific vaccines and antivirals have been licensed, efforts to develop candidates offering broad species cross-protection are continuing....
Cross-Neutralisation of Novel Bombali Virus by Ebola Virus Antibodies and Convalescent Plasma Using an Optimised Pseudotype-Based Neutralisation Assay.
Emma M Bentley, Samuel Richardson, Mariliza Derveni, Pramila Rijal, Alain R Townsend, Jonathan L Heeney, Giada Mattiuzzo, Edward Wright
Sep 27, 2021
Ebolaviruses continue to pose a significant outbreak threat, and while Ebola virus (EBOV)-specific vaccines and antivirals have been licensed, efforts to develop candidates offering broad species cross-protection are continuing....
Published by: Tropical medicine and infectious disease
Cross-Neutralisation of Novel Bombali Virus by Ebola Virus Antibodies and Convalescent Plasma Using an Optimised Pseudotype-Based Neutralisation Assay
Emma M. Bentley, Samuel Richardson, Mariliza Derveni, Pramila Rijal, Alain R. Townsend, Jonathan L. Heeney, Giada Mattiuzzo, Edward Wright
Aug 27, 2021
Ebolaviruses continue to pose a significant outbreak threat, and while Ebola virus (EBOV)-specific vaccines and antivirals have been licensed, efforts to develop candidates offering broad species cross-protection are continuing....